Taiwan FDA registration 46c3bd883957ad394668793115b60ee9
"Termao" Rheos automatic blood processing system
TW: "泰爾茂" 瑞歐斯自動血液處理系統
Taiwan·Risk Class 2·Terumo BCT, Inc·Registered Jun 08, 2022 – Jun 08, 2027ActiveRegistration details
- Analysis ID
- 46c3bd883957ad394668793115b60ee9
- Customs Code
- DHA05603565700
Company information
- Manufacturer
- Terumo BCT, Inc
- Manufacturer Country
- United States
- Authorized Representative
- TERUMO TAIWAN MEDICAL CO., LTD.
Product details
- Intended Use
- This product is used to automatically separate whole blood units into blood components, and Reveos programs and data can be managed through TOMEs (Terumo Operational Medical Equipment Software).
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Jun 08, 2022
- Expiry Date
- Jun 08, 2027
About this record
Access comprehensive regulatory information for "Termao" Rheos automatic blood processing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 46c3bd883957ad394668793115b60ee9 and manufactured by Terumo BCT, Inc. The authorized representative in Taiwan is TERUMO TAIWAN MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices